Clinical Trial Update: N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of irinotecan and vincristine with 131I-MIBG radiotherapy for resistant/relapsed high-risk neuroblastoma has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• 131I-MIBG therapy (iodine-131-metaiodobenzylguanidine)
• Camptosar (irinotecan)
• Oncovin (vincristine)

Snippet

Sponsor: New Approaches to Neuroblastoma Therapy Consortium | Conditions: Neuroblastoma | Phase 1 | Status: COMPLETED